How Are ADCs Improving Cancer Treatments With Precision

ADCs could lead to better and more efficient treatments in the complex and specialized field of tailored cancer medicines. ADCs are made up of a monoclonal antibody that is permanently linked to a lethal drug. They were created as biological missiles with the goal of being very specific in their targets and having very strong […]

Crown Laboratories and Revance Announce Entry Into Merger Agreement

Crown Laboratories, Inc., a privately held, global innovative leader in the skincare industry, and Revance Therapeutics, Inc., a biotechnology company aimed at setting the new standard in healthcare with innovative aesthetic and therapeutic offerings, today announced that they have entered into a merger agreement pursuant to which the companies seek to merge the two complementary […]

Tonix advances development of TNX-801 to prevent mpox infection

Tonix Pharmaceuticals Holding Corp., a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, has reiterated its commitment to advance development of its live attenuated virus vaccine, TNX-801 , for preventing mpox and other infectious diseases. On August 14, 2024, the World Health Organization (WHO) determined that the upsurge of mpox in […]

LSPedia & Pharma Logistics Partner to revolutionize pharmaceutical reverse logistics and supply chain visibility

LSPedia, a SaaS solution leader in global product traceability, announces a strategic partnership with Pharma Logistics, the industry leader in pharmaceutical reverse distribution. This collaboration aims to transform the pharmaceutical supply chain by offering turnkey compliance, unprecedented data visibility, and robust supply chain efficiency. Compliance is at the core of Pharma Logistics’ business model, aligning […]

Nuntius Therapeutics Announces Collaboration with Taiho Pharmaceutical to Develop Next-Generation mRNA Therapies

Nuntius Therapeutics, a biotech company developing transformative mRNA therapies through their advanced delivery technology announced that they have entered into a collaboration agreement with Taiho Pharmaceutical Co., Ltd. (“Taiho”), a leading company in Japan for developing innovative medicines for the treatment of cancer. Taiho will use Nuntius’ cell-specific peptide dendrimer- and lipid-based nanocarriers to develop […]

AstraZeneca Monotherapy for Gastric Cancer Gains Third Approval in China

AstraZeneca and Daiichi Sankyo’s Enhertu has received conditional approval in China as a monotherapy for the treatment of adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma who have received two or more prior treatment regimens. The conditional approval by the National Medical Products Administration (NMPA) was based on the […]

Nanoform and Takeda to Collaborate on Plasma-Derived Therapy Formulation

Nanoform Finland Plc , the medicine performance-enhancing company announced that it is to enter into a pre-clinical development agreement with the Plasma-derived Therapies Business Unit of Takeda Pharmaceuticals, Inc., the R&D-driven biopharmaceutical company headquartered in Japan, to develop innovative plasma-derived therapy formulations for the treatment of rare conditions. Following the completion of in vitro proof […]

Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care Segment to Carlyle for $3.8 Billion

Baxter International Inc., a global medtech leader, and funds managed by global investment firm Carlyle announced that they have signed a definitive agreement under which Carlyle is to acquire Baxter’s Kidney Care segment, to be named Vantive, for $3.8 billion. Under the terms of the definitive agreement, subject to certain closing adjustments, Baxter will receive […]

Phastar named in 2024 Environment 100 List

Phastar, global specialist biometrics contract research organization (CRO), has been recognized in the 2024 Environment 100 List, led by Graham Clark. The award is further recognition of Phastar’s commitment to being a purpose-led organization which is leading the CRO industry in corporate responsibility. The Environment 100 List shines a light on the trailblazers and visionaries […]

Daiichi And MSD Broaden DXd ADC Collaboration Worldwide

Daiichi Sankyo and MSD have widened their partnership to create and market three DXd-based antibody-drug conjugates (ADCs) all over the world. DXd is the name of Daiichi Sankyo’s unique ADC technology platform. MK-6070, MSD’s delta-like ligand 3 (DLL3) targeting T-cell engager, will be part of the deal. As part of its purchase of Harpoon Therapeutics, […]